Compugen to Participate in Upcoming Fierce Biotech Summit :

/PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today,...

Related Keywords

Boston , Massachusetts , United States , Israel , Tel Aviv , Yaron Turpaz , Yvonne Naughton , Compugen Ltd , Stock Exchange , Compugen , Nasdaq , Drug Development , Astrazeneca , Corporate Communications , Senior Advisor , Computational Discovery , Senior Vice President , Fierce Biotech Summit , Advance Discovery , Accelerate Drug , South San Francisco , Investor Relations , Health Care Amp Hospitals , Pharmaceuticals , Medical Pharmaceuticals , Biotechnology , Trade Show News ,